AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

AngioDynamics (ANGO) Granted FDA Approval to Begin NanoKnife DIRECT Clinical Study for Treatment of Stage III Pancreatic CancerApril 1, 2019 6:09 AM OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation TherapyMarch 28, 2019 4:01 PM